HDAC inhibitors (Argenta)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHDAC inhibitors (Argenta)
Drug Alias Namehydroxamic acid histone deacetylase inhibitors (Argenta)HDAC inhibitors (Argenta)ADS-100380
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArgenta Discovery
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArgenta Discovery
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A